Supernus Pharmaceuticals, Inc. company logo
Supernus Pharmaceuticals, Inc. logo

Supernus Pharmaceuticals, Inc. (SUPN) Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$453.61M$198.74M+77.97%

Summary

Current Value
As of today, SUPN annual cash & cash equivalents is $453.61M, up +77.97% on
Historical Performance
SUPN annual cash & cash equivalents is up +33.54% over the past 3 years, with unknown 5-year change
All-Time High Comparison
SUPN annual cash & cash equivalents is currently -1.67% below its historical high of $461.33M set on
3-Year Low Comparison
SUPN annual cash & cash equivalents is +77.97% above its 3-year low of $254.87M reached on
Sector Comparison
SUPN annual cash & cash equivalents is higher than 88.39% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

SUPN Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$453.61M+78.0%+33.5%+1344.3%
Quarterly Cash & Cash Equivalents$281.16M-30.3%-28.2%-20.1%+1013.2%
Price$51.24+36.9%+30.1%+92.9%
Annual Current Assets$686.07M+39.1%+14.0%+45.2%+841.4%
Annual Total Liabilities$465.07M-4.6%-54.3%+440.4%
Annual Working Capital$393.67M+94.0%+37.5%+26.1%+526.4%
Annual Net Income$73.87M+5512.8%+38.3%-34.7%+1685.0%

Cash and Cash Equivalents Highs

SUPN Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$461.33MN/A-1.7%
5Y$461.33M-1.7%
All$461.33M-1.7%

Cash and Cash Equivalents Lows

SUPN Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$254.87M+78.0%
5Y$254.87M+78.0%
All$23.74M+1810.8%

Cash and Cash Equivalents History

YearValueChange
$453.61M+78.0%
$254.87M-44.8%
$461.33M+35.8%
$339.68M-19.6%
$422.53M+201.7%
YearValueChange
$140.04M+55.4%
$90.12M+44.9%
$62.19M+70.9%
$36.40M-

FAQ

  • What is the current annual cash & cash equivalents of SUPN?

    As of today, SUPN annual cash & cash equivalents is $453.61M

  • What is 1-year change in SUPN annual cash & cash equivalents?

    SUPN annual cash & cash equivalents is up +77.97% year-over-year

  • What is 3-year change in SUPN annual cash & cash equivalents?

    SUPN annual cash & cash equivalents is up +33.54% over the past 3 years

  • How far is SUPN annual cash & cash equivalents from its all-time high?

    SUPN annual cash & cash equivalents is currently -1.67% below its historical high of $461.33M set on December 31, 2022

  • How does SUPN annual cash & cash equivalents rank versus sector peers?

    SUPN annual cash & cash equivalents is higher than 88.39% of companies in Healthcare sector

  • When is SUPN next annual earnings release?

    The next annual earnings release for SUPN is on

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. SUPN Official Website www.supernus.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1356576/000135657625000071/0001356576-25-000071-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1356576/000135657625000017/0001356576-25-000017-index.htm
  4. SUPN Profile on Yahoo Finance finance.yahoo.com/quote/SUPN
  5. SUPN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/supn